BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 32003687)

  • 1. Human-Induced Pluripotent Stem Cell-Derived Hepatocytes and their Culturing Methods to Maintain Liver Functions for Pharmacokinetics and Safety Evaluation of Pharmaceuticals.
    Inoue T; Iwazaki N; Araki T; Hitotsumachi H
    Curr Pharm Biotechnol; 2020; 21(9):773-779. PubMed ID: 32003687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemically induced hepatotoxicity in human stem cell-induced hepatocytes compared with primary hepatocytes and HepG2.
    Kang SJ; Lee HM; Park YI; Yi H; Lee H; So B; Song JY; Kang HG
    Cell Biol Toxicol; 2016 Oct; 32(5):403-17. PubMed ID: 27287938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A transcriptomic study suggesting human iPSC-derived hepatocytes potentially offer a better in vitro model of hepatotoxicity than most hepatoma cell lines.
    Gao X; Liu Y
    Cell Biol Toxicol; 2017 Aug; 33(4):407-421. PubMed ID: 28144825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation of expandable human pluripotent stem cell-derived hepatocyte-like liver organoids.
    Mun SJ; Ryu JS; Lee MO; Son YS; Oh SJ; Cho HS; Son MY; Kim DS; Kim SJ; Yoo HJ; Lee HJ; Kim J; Jung CR; Chung KS; Son MJ
    J Hepatol; 2019 Nov; 71(5):970-985. PubMed ID: 31299272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Feeder-free and serum-free production of hepatocytes, cholangiocytes, and their proliferating progenitors from human pluripotent stem cells: application to liver-specific functional and cytotoxic assays.
    Nakamura N; Saeki K; Mitsumoto M; Matsuyama S; Nishio M; Saeki K; Hasegawa M; Miyagawa Y; Ohkita H; Kiyokawa N; Toyoda M; Akutsu H; Umezawa A; Yuo A
    Cell Reprogram; 2012 Apr; 14(2):171-85. PubMed ID: 22384928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Highly efficient and expedited hepatic differentiation from human pluripotent stem cells by pure small-molecule cocktails.
    Du C; Feng Y; Qiu D; Xu Y; Pang M; Cai N; Xiang AP; Zhang Q
    Stem Cell Res Ther; 2018 Mar; 9(1):58. PubMed ID: 29523187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of Human Induced Pluripotent Stem Cell-Derived Hepatocytes with Mature Features and Potential for Modeling Metabolic Diseases.
    Holmgren G; Ulfenborg B; Asplund A; Toet K; Andersson CX; Hammarstedt A; Hanemaaijer R; Küppers-Munther B; Synnergren J
    Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31940797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 3-D culture and endothelial cells improve maturity of human pluripotent stem cell-derived hepatocytes.
    Ardalani H; Sengupta S; Harms V; Vickerman V; Thomson JA; Murphy WL
    Acta Biomater; 2019 Sep; 95():371-381. PubMed ID: 31362140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Critical differences in drug metabolic properties of human hepatic cellular models, including primary human hepatocytes, stem cell derived hepatocytes, and hepatoma cell lines.
    Kvist AJ; Kanebratt KP; Walentinsson A; Palmgren H; O'Hara M; Björkbom A; Andersson LC; Ahlqvist M; Andersson TB
    Biochem Pharmacol; 2018 Sep; 155():124-140. PubMed ID: 29953844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human Induced Pluripotent Stem Cell-Derived Definitive Endoderm Bulk Culture and Hepatic Differentiation.
    Palakkan AA; Nanda J; Ross JA
    Methods Mol Biol; 2019; 1994():41-53. PubMed ID: 31124103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retaining mTeSR1 Medium during Hepatic Differentiation Facilitates Hepatocyte-Like Cell Survival by Decreasing Apoptosis.
    Hou J; Long Y; Hu B; Huang S; Xu G; Gao T; Wu F; Li Y; Wu ZK
    Cell Physiol Biochem; 2018; 51(4):1533-1543. PubMed ID: 30497075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Animal models to test hiPS-derived hepatocytes in the context of inherited metabolic liver diseases.
    Dusséaux M; Darche S; Strick-Marchand H
    Methods Mol Biol; 2014; 1213():81-8. PubMed ID: 25173376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generation of hepatocyte-like cells from human induced pluripotent stem (iPS) cells by co-culturing embryoid body cells with liver non-parenchymal cell line TWNT-1.
    Javed MS; Yaqoob N; Iwamuro M; Kobayashi N; Fujiwara T
    J Coll Physicians Surg Pak; 2014 Feb; 24(2):91-6. PubMed ID: 24491001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human hepatocytes derived from pluripotent stem cells: a promising cell model for drug hepatotoxicity screening.
    Gómez-Lechón MJ; Tolosa L
    Arch Toxicol; 2016 Sep; 90(9):2049-2061. PubMed ID: 27325232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional Maturation of Induced Pluripotent Stem Cell Hepatocytes in Extracellular Matrix-A Comparative Analysis of Bioartificial Liver Microenvironments.
    Wang B; Jakus AE; Baptista PM; Soker S; Soto-Gutierrez A; Abecassis MM; Shah RN; Wertheim JA
    Stem Cells Transl Med; 2016 Sep; 5(9):1257-67. PubMed ID: 27421950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An Efficient Method for the Differentiation of Human iPSC-Derived Endoderm toward Enterocytes and Hepatocytes.
    Qiu S; Li Y; Imakura Y; Mima S; Hashita T; Iwao T; Matsunaga T
    Cells; 2021 Apr; 10(4):. PubMed ID: 33917333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maturation of induced pluripotent stem cell derived hepatocytes by 3D-culture.
    Gieseck RL; Hannan NR; Bort R; Hanley NA; Drake RA; Cameron GW; Wynn TA; Vallier L
    PLoS One; 2014; 9(1):e86372. PubMed ID: 24466060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficient generation of hepatocyte-like cells from human induced pluripotent stem cells.
    Song Z; Cai J; Liu Y; Zhao D; Yong J; Duo S; Song X; Guo Y; Zhao Y; Qin H; Yin X; Wu C; Che J; Lu S; Ding M; Deng H
    Cell Res; 2009 Nov; 19(11):1233-42. PubMed ID: 19736565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced antioxidant capacity of dental pulp-derived iPSC-differentiated hepatocytes and liver regeneration by injectable HGF-releasing hydrogel in fulminant hepatic failure.
    Chiang CH; Wu WW; Li HY; Chien Y; Sun CC; Peng CH; Lin AT; Huang CS; Lai YH; Chiou SH; Hung SI; Chang YL; Lan YT; Liu DM; Chien CS; Huo TI; Lee SD; Wang CY
    Cell Transplant; 2015; 24(3):541-59. PubMed ID: 25668102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reprogramming induced pluripotent stem cells in the absence of c-Myc for differentiation into hepatocyte-like cells.
    Li HY; Chien Y; Chen YJ; Chen SF; Chang YL; Chiang CH; Jeng SY; Chang CM; Wang ML; Chen LK; Hung SI; Huo TI; Lee SD; Chiou SH
    Biomaterials; 2011 Sep; 32(26):5994-6005. PubMed ID: 21658760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.